Pfizer Boosts Forecast for Vaccine Sales to $33.5 Billion

Bloomberg (07/28/2021)
  • Pfizer raised its full-year Covid vaccine revenue forecast from $26B to $33.5B as demand surges following the Delta variant outbreak.
  • Revenues could rise further if US regulators authorize a third booster shot to fight new variants.
  • Pfizer also plans on creating a new vaccine formulation designed to fight the Delta variant.
  • Rising demand could make Pfizer Covid vaccine one of the best-selling drugs ever, outpacing Merck’s Keytruda cancer treatment.
  • Pfizer’s total 2021 revenue is forecast to reach $78-80 billion.